According to the research report titled ‘Europe Prebiotics Market Size By Ingredient, Application, Application Potential, Competitive Market Share & Forecast, 2020 - 2026‘, available with Market Study Report, Europe prebiotics market is predicted to reach USD 3.5 billion by the year 2026.
 

Rising customer awareness regarding consumption of high quality protein & fiber to maintain nutritional levels in the body along with increasing incidences of several lifestyle disorders such as diabetes, obesity, and cardiovascular diseases are expected to accelerate the growth of Europe prebiotics market during the forecast period.  
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2609893/
 

Based on ingredient type, insulin segment of Europe prebiotics market is estimated to register 9% growth rate through 2026, due to various health benefits of product as well as its ability to nourish colon cells. Furthermore, inulin acts as fat substitute, helps in sugar reduction, and plays a major part in growth of intestinal bacteria. Utilization of the ingredient in several healthy products mainly due to its ability to enhance texture and sweet taste is boosting the demand for insulin based prebiotics.
 

Moving on to application scope, Europe prebiotics market from dietary supplement segment is estimated to surpass USD 420 million by the year 2026, due to usage of insulin and FOS in supplemental formulations, mainly because of their ability to control blood sugar levels, enhance digestive health, and promote healthy cellular growth.
 

According to the report, prebiotics market remuneration from infant formulations application in UK is poised to exceed USD 4.5 million by 2026. Prebiotics in infant formula strengthens baby’s health, enhances baby skin, and improves immune system. Furthermore, consumption of prebiotic formulas facilitates balance of bacteria in baby's intestines and demotes formation of harmful bacteria.
 

From the regional frame of reference, Germany prebiotics market size is likely to expand with CAGR of 9% during the forecasted timeframe. Cognizance regarding several benefits of prebiotics such as improvement in mineral absorption, inhibition of insulin secretion, and balanced gut & heart health are favoring the product adoption across Germany.
 

Key players operating in Europe prebiotics industry are DuPont, Solvay, Cargill Inc., BENEO GmbH, Weetabix Ltd., Cosucra Groupe Warcoing SA, FrieslandCampina N.V., Sigma-Aldrich, Abbott Laboratories, Roquette Freres, Parmalat S.p.A, and SOLACTIS Group.